FDA Advisory Letters

FDA Advisory Letters are official communications issued by the U.S. Food and Drug Administration (FDA). These letters inform companies about potential violations related to food, drugs, medical devices, and other regulated products. They serve as important guidance on how to comply with FDA regulations and safeguard public health. Advisory letters may address concerns about labeling, marketing practices, or safety issues.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
53 Entities in FDA Advisory Letters
Entity NameEntity TypeEffective DateStatus

Upper Echelon Empire Beauty Health Co

CompanyMay 23, 2024active

Leading Edge Health

CompanyJul 25, 2019active

ALIVEBYNATURE INC

CompanyJul 25, 2019active

ARS Therapeutics LLC

CompanyJun 29, 2017active

Doctor Eden LLC

CompanyJul 25, 2019active

ActiveHerb Technology Inc

CompanyAug 4, 2015active

CellMark Biopharma LLC

CompanyFeb 13, 2017active

Prostalgene LLC

CompanyDec 6, 2017active

Alzheimers Corporation ALZcorp

CompanyNov 8, 2018active

Super Sprout LLC

CompanyJun 29, 2017active

FAQs

Why is compliance with FDA Advisory Letters necessary?

FDA Advisory Letters play a crucial role in ensuring that businesses comply with health and safety regulations. these letters are issued by the food and drug administration (fda) when they identify issues with products, marketing, or business practices that may pose risks to public health. compliance with these letters is essential for several reasons.

Which companies should comply with FDA Advisory Letters?

The FDA advisory letters are important for companies in the food and drug industries. This includes food manufacturers, pharmaceutical companies, and medical device makers. Compliance is crucial because these letters provide guidance on regulations and safety standards. Following these guidelines helps companies avoid penalties, ensures consumer safety, and maintains a good reputation in the market.